As Celgene Corp (CELG) Stock Price Declined, Holder Quantitative Investment Management LLC Has Raised Its Position

December 7, 2017 - By Dolores Ford

Investors sentiment increased to 1.34 in Q2 2017. Its up 0.21, from 1.13 in 2017Q1. It increased, as 60 investors sold CELG shares while 390 reduced holdings. 110 funds opened positions while 494 raised stakes. 602.51 million shares or 1.81% more from 591.78 million shares in 2017Q1 were reported. Sumitomo Mitsui reported 2.45M shares. Jane Street Group Ltd Liability Corporation holds 45,520 shares. Green Valley Investors Lc stated it has 9.14% of its portfolio in Celgene Corporation (NASDAQ:CELG). Blue Edge Ltd reported 13,808 shares or 0% of all its holdings. American Rech & Co holds 0.87% in Celgene Corporation (NASDAQ:CELG) or 20,330 shares. Park National Corporation Oh has 3,699 shares. Cahill Fincl, Minnesota-based fund reported 2,034 shares. Tanaka Cap Mgmt holds 4.15% of its portfolio in Celgene Corporation (NASDAQ:CELG) for 13,945 shares. Klingenstein Fields Co Llc holds 0.92% or 180,663 shares. Zwj Invest Counsel invested in 220,397 shares. 193,618 were accumulated by Arizona State Retirement System. Assetmark reported 0.02% of its portfolio in Celgene Corporation (NASDAQ:CELG). Cibc Ww Mkts owns 204,143 shares. Alphamark Advsrs Limited Liability Corp stated it has 0% in Celgene Corporation (NASDAQ:CELG). Tokio Marine Asset Mgmt, Japan-based fund reported 97,863 shares.

Since June 15, 2017, it had 0 insider buys, and 3 selling transactions for $2.36 million activity. Another trade for 5,000 shares valued at $625,000 was sold by Friedman Michael A. $575,038 worth of Celgene Corporation (NASDAQ:CELG) was sold by VESSEY RUPERT on Thursday, June 15.

Quantitative Investment Management Llc increased its stake in Celgene Corp (CELG) by 752.54% based on its latest 2017Q2 regulatory filing with the SEC. Quantitative Investment Management Llc bought 429,700 shares as the company’s stock declined 3.49% while stock markets rallied. The hedge fund held 486,800 shares of the major pharmaceuticals company at the end of 2017Q2, valued at $63.22 million, up from 57,100 at the end of the previous reported quarter. Quantitative Investment Management Llc who had been investing in Celgene Corp for a number of months, seems to be bullish on the $80.73 billion market cap company. The stock increased 0.36% or $0.37 during the last trading session, reaching $102.54. About 2.37M shares traded. Celgene Corporation (NASDAQ:CELG) has risen 17.00% since December 7, 2016 and is uptrending. It has outperformed by 0.30% the S&P500.

Quantitative Investment Management Llc, which manages about $1.89B and $6.65 billion US Long portfolio, decreased its stake in Cadence Design Systems Inc (NASDAQ:CDNS) by 307,500 shares to 44,000 shares, valued at $1.47 million in 2017Q2, according to the filing. It also reduced its holding in Ellie Mae Inc (NYSE:ELLI) by 79,200 shares in the quarter, leaving it with 61,000 shares, and cut its stake in Tableau Software Inc (NYSE:DATA).

More notable recent Celgene Corporation (NASDAQ:CELG) news were published by: which released: “to Support Cancer Healthcare Capacity Building in Resource-Constrained Countries” on December 05, 2017, also with their article: “Celgene Corporation to Webcast an Analyst and Investor Event from the American …” published on November 21, 2017, published: “Celgene Corporation and bluebird bio Announce bb2121 Anti-BCMA CAR-T Cell …” on November 16, 2017. More interesting news about Celgene Corporation (NASDAQ:CELG) were released by: and their article: “Celgene: Revlimid’s Price Hikes Could Attract Senate’s Attention” published on November 27, 2017 as well as‘s news article titled: “Celgene Is Oversold, Buy And Keep Until At Least 2020” with publication date: November 30, 2017.

Celgene Corporation (NASDAQ:CELG) Ratings Coverage

Among 31 analysts covering Celgene Corporation (NASDAQ:CELG), 20 have Buy rating, 2 Sell and 9 Hold. Therefore 65% are positive. Celgene Corporation has $190 highest and $83 lowest target. $139.75’s average target is 36.29% above currents $102.54 stock price. Celgene Corporation had 111 analyst reports since July 21, 2015 according to SRatingsIntel. The stock of Celgene Corporation (NASDAQ:CELG) earned “Market Outperform” rating by JMP Securities on Wednesday, March 9. RBC Capital Markets maintained Celgene Corporation (NASDAQ:CELG) rating on Wednesday, October 4. RBC Capital Markets has “Buy” rating and $173.0 target. Canaccord Genuity maintained the stock with “Buy” rating in Friday, October 27 report. JMP Securities downgraded the stock to “Hold” rating in Friday, October 27 report. The stock of Celgene Corporation (NASDAQ:CELG) earned “Outperform” rating by BMO Capital Markets on Friday, November 17. Raymond James initiated the stock with “Strong-Buy” rating in Tuesday, September 1 report. The stock of Celgene Corporation (NASDAQ:CELG) has “Buy” rating given on Friday, July 24 by Cantor Fitzgerald. The rating was initiated by Suntrust Robinson with “Buy” on Thursday, January 7. The stock of Celgene Corporation (NASDAQ:CELG) earned “Buy” rating by Cowen & Co on Tuesday, September 12. The stock has “Buy” rating by Cantor Fitzgerald on Thursday, July 27.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.